Pharmaron
↗Beijing, China
Pharmaron is a premier global Contract Research, Development, and Manufacturing Organization (CRO/CDMO) providing a fully integrated platform for the life sciences industry. Founded in 2004, the company supports the entire drug discovery and development lifecycle, from early-stage synthetic chemistry and biology to preclinical safety assessment, clinical trials, and commercial-scale manufacturing.
With a significant presence in China, the United States, and the United Kingdom, Pharmaron serves over 2,200 global partners, including all of the top 20 pharmaceutical companies. The company is particularly recognized for its expertise in small molecules, biologics, and emerging modalities such as Cell and Gene Therapy (CGT) and Antibody-Drug Conjugates (ADCs).
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Revenue:$1.8B-$2.0B
Founded:2004
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$320M (Pre-IPO)
Investors:Legend Capital, GL Capital Group, CITIC PE
STOCK
Exchange:SHE / HKEX
Ticker:300759.SZ / 3759.HK
Market Cap:$7.3B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Biologics, Cell therapy, Gene therapy, ADC, Peptides, Oligonucleotides
Active Trials:150
Trial Phases:Phase 1: 80 | Phase 2: 40 | Phase 3: 25 | Phase 4: 5
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Pharmaron US, Pharmaron UK, Absorption Systems, Aesica Pharmaceuticals, Biortus Biosciences
Key Partnerships:CN Bio (Organ-on-a-chip technology), TheraCryf (Addiction program development), AstraZeneca (Strategic R&D support)
COMPETITION
Position:Leader
Competitors:WuXi AppTec, Charles River Laboratories, IQVIA, Syngene International, Evotec, Labcorp Drug Development
LEADERSHIP
Key Executives:
Boliang Lou - Chairman & CEO
Larry Lou - President & COO
Hua Yang - Chief Scientific Officer
Scientific Founders:Boliang Lou, Larry Lou, Bei Zheng
Board Members:Boliang Lou, Bei Zheng, Gilbert Li, Katherine Lee
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Pharmaron. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.